Non-invasive Biosensors Market - Global Forecast, 2022 - 2028

Non-invasive Biosensors Market - Global Forecast, 2022 - 2028

Non-invasive biosensors are novel diagnosis devices, which do not require any invasive procedure for detection of any substance or disease. This technology uses sweat, tears, or saliva for diagnostic purpose. Glucose monitoring and blood analytes monitor have become available in the market, which uses non-invasive biosensors. Moreover, there are many non-invasive biosensors under development and under clinical trial for new applications such as cancer and blood alcohol concentration detection.
Market Dynamics
Increasing approval and launches of novel non-invasive biosensors is expected to boost growth of global non-invasive biosensors market in the near future. For instance, in 2016, Nemaura Medical, Inc. received CE approval in the European Union for its latest sugarBEAT, a minimally invasive wireless continuous glucose monitor. Moreover, in 2013, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device. Increasing research and development activities for developing novel non-invasive biosensors is also expected to drive growth of market in the near future. For instance, in 2021, Mclean Hospital announced that LabPatch-alcohol, its non-invasive skin patch that detects blood alcohol concentration, is in clinical trial. LabPatch-alcohol is in early Phase 1 stage of clinical trial. Furthermore, increasing prevalence of diabetes is also expected to increase demand for non-invasive biosensors for diagnosis. According to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide.
Key features of the study:
This report provides in-depth analysis of non-invasive biosensors market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global non-invasive biosensors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global non-invasive biosensors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-invasive biosensors market
Detailed Segmentation:
Global Non-Invasive Biosensors Market, By Technology :
Optical
Transdermal
Thermal
Others
Global Non-Invasive Biosensors Market, By Product Type:
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
Global Non-Invasive Biosensors Market, By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
Global Non-Invasive Biosensors Market, By Geography:
North America
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
U.S.
Canada
Europe
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technology :
Optical
Transdermal
Thermal
Others
By Product Type
Glucose Monitors
Blood Analytes Monitors
Breathalyzers
Others
By End User:
Hospital
Diagnostic Lab
Homecare Settings
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Nemaura Medical, Inc.*
Company Overview
Product Portfolio
Recent Developments
Financial Performance
Key Strategies
MediWise Ltd.
Integrity Applications Inc.
OrSense
Medtronic Plc
GE Healthcare
Philips Healthcare
Akers Biosciences, Inc.
Abbott Laboratories
“*” marked represents similar segmentation in other categories in the respective section.